First Eagle Value in Biotechnology Master Fund, Ltd. insider trades: Durect (DRRX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where First Eagle Value in Biotechnology Master Fund, Ltd. reports to the SEC
Open-market buys and sales
22 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 20, 2019 | DRRX | ↑ Buy | 4,000,000 | $0.52 | $2.1M | Indirect | Jun 24, 2019 (4d) |
| Feb 15, 2018 | IVAC | ↑ Buy | 23,391 | $6.25 | $146K | Indirect | Feb 15, 2018 (0d) |
| Feb 12, 2018 | IVAC | ↑ Buy | 35,272 | $6.21 | $219K | Indirect | Feb 13, 2018 (1d) |
| Feb 8, 2018 | IVAC | ↑ Buy | 21,300 | $6.32 | $135K | Indirect | Feb 9, 2018 (1d) |
| Feb 6, 2018 | IVAC | ↑ Buy | 86,332 | $6.33 | $546K | Indirect | Feb 7, 2018 (1d) |
| Feb 2, 2018 | IVAC | ↑ Buy | 45,908 | $6.56 | $301K | Indirect | Feb 5, 2018 (3d) |
| Jan 31, 2018 | IVAC | ↑ Buy | 88,183 | $6.81 | $601K | Indirect | Feb 1, 2018 (1d) |
| May 9, 2017 | IVAC | ↓ Sell | 67,554 | $13.02 | $880K | Indirect | May 10, 2017 (1d) |
| May 3, 2017 | IVAC | ↓ Sell | 37,187 | $13.28 | $494K | Indirect | May 4, 2017 (1d) |
| May 1, 2017 | IVAC | ↓ Sell | 33,231 | $13.00 | $432K | Indirect | May 2, 2017 (1d) |
| Apr 27, 2017 | IVAC | ↓ Sell | 116,815 | $13.02 | $1.5M | Indirect | Apr 28, 2017 (1d) |
| Apr 25, 2017 | IVAC | ↓ Sell | 338,857 | $13.44 | $4.6M | Indirect | Apr 26, 2017 (1d) |
| Nov 3, 2016 | DRRX | ↑ Buy | 95,000 | $1.16 | $110K | Indirect | Nov 4, 2016 (1d) |
| Sep 26, 2016 | DRRX | ↑ Buy | 2,500,000 | $1.15 | $2.9M | Direct | Sep 28, 2016 (2d) |
| Apr 26, 2016 | DRRX | ↑ Buy | 5,500,000 | $1.25 | $6.9M | Direct | Apr 27, 2016 (1d) |
| Jan 11, 2016 | DRRX | ↑ Buy | 300,100 | $1.37 | $411K | Direct | Jan 12, 2016 (1d) |
| Sep 29, 2015 | DRRX | ↑ Buy | 952,249 | $1.79 | $1.7M | Direct | Oct 1, 2015 (2d) |
| Mar 16, 2015 | DRRX | ↑ Buy | 1,668,800 | $1.70 | $2.8M | Direct | Mar 20, 2015 (4d) |
| Aug 27, 2013 | ARDM | ↑ Buy | 40,322,580 | $0.12 | $5.0M | Indirect | Aug 29, 2013 (2d) |
| Dec 11, 2012 | ARDM | ↑ Buy | 41,666,667 | $0.12 | $5.0M | Indirect | Dec 13, 2012 (2d) |
| Jul 7, 2011 | ARDM | ↑ Buy | 10,625,000 | $0.19 | $2.0M | Indirect | Jul 11, 2011 (4d) |
| Jun 18, 2010 | ARDM | ↑ Buy | 19,433,408 | $0.12 | $2.3M | See remarks, note (1). | Jun 22, 2010 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About First Eagle Value in Biotechnology Master Fund, Ltd.'s insider trades
First Eagle Value in Biotechnology Master Fund, Ltd. is a 10% owner of Durect (DRRX). Since Jun 18, 2010, it has reported 17 open-market purchases worth $33.2M and 5 sales worth $7.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (9 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DRRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.